Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
Top Cited Papers
- 1 November 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (21) , 11196-11200
- https://doi.org/10.1128/jvi.01899-08
Abstract
To reliably infect a primate model for human immunodeficiency virus (HIV), ∼10,000-fold more virus must be delivered vaginally than intravenously. However, the vaginal mechanisms that help protect against HIV are poorly understood. Here, we report that human cervicovaginal mucus (CVM), obtained from donors with normal lactobacillus-dominated vaginal flora, efficiently traps HIV, causing it to diffuse more than 1,000-fold more slowly than it does in water. Lactobacilli acidify CVM to pH ∼4 by continuously producing lactic acid. At this acidic pH, we found that lactic acid, but not HCl, abolished the negative surface charge on HIV without lysing the virus membrane. In contrast, in CVM neutralized to pH 6 to 7, as occurs when semen temporarily neutralizes the vagina, HIV maintained its native surface charge and diffused only 15-fold more slowly than it would in water. Thus, methods that can maintain both a high lactic acid content and acidity for CVM during coitus may contribute to both vaginal and penile protection by trapping HIV before it can reach target cells. Our results reveal that CVM likely plays an important but currently unappreciated role in decreasing the rate of HIV sexual transmission.Keywords
This publication has 35 references indexed in Scilit:
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Altering Mucus Rheology to “Solidify” Human Mucus at the NanoscalePLOS ONE, 2009
- Micro- and macrorheology of mucusPublished by Elsevier ,2009
- Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesAIDS, 2008
- Preventing Sexual Transmission of HIVClinical Infectious Diseases, 2007
- REVIEW ARTICLE: Antimicrobial Polypeptides are Key Anti‐HIV‐1 Effector Molecules of Cervicovaginal Host DefenseAmerican Journal of Reproductive Immunology, 2007
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007
- Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cellVirology, 2006
- Leukocytes Migrate through Three-Dimensional Gels of Midcycle Cervical MucusCellular Immunology, 1994
- Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission.The Journal of Experimental Medicine, 1991